Mounting scientific evidence continues to link paraquat exposure to Parkinson’s disease, raising serious questions about how the herbicide was marketed and used for decades. The primary defendants in the litigation include Syngenta and Chevron, tied to paraquat-containing products such as Gramoxone and other branded herbicides.
Pursuing this tort offers an opportunity to support affected individuals, seek compensation, and promote stronger safety standards in agricultural chemical use.
Paraquat Use and Exposure Overview
Paraquat (paraquat dichloride), one of the most widely used herbicides in the world, is used as a weed killer for more than 100 crops including cotton, soybeans, corn, and orchards.
Exposure in the United States has been extensive:
- An estimated 8–10 million pounds are applied each year.
- 500,000–900,000 agricultural workers may have been exposed in the U.S.
- High-risk groups include farmworkers, applicators, mixers, and loaders.
- Residents living within 500 meters of treated fields face elevated exposure risk.
- Mixing and loading pose the highest risk, even compared to direct application.
Paraquat has been banned in more than 32 countries, including the EU, China, and Brazil, due to safety concerns. Despite these international restrictions, its use is still widespread domestically in the United States.
Legal Basis for Paraquat Claims
Central to Paraquat litigation is the growing evidence connecting exposure to the chemical with Parkinson’s disease. Research shows paraquat crosses the blood–brain barrier, accumulates in the substantia nigra, and is associated with increased Parkinson’s risk.
These findings have prompted federal and state complaints that focus on several key allegations:
- Manufacturers knew or should have known about paraquat’s neurotoxic risks.
- Internal documents may indicate awareness of these risks as early as the 1970s–1980s.
- Despite widespread international bans, U.S. sales continued for decades.
- Product labels did not adequately warn about the risk of Parkinson’s disease.
- Manufacturers failed to conduct long-term neurological safety studies.
- Safer alternative herbicides are available, but are less profitable for the manufacturer.
These facts form the basis of claims involving inadequate warnings, negligent design, misrepresentation, and related product liability theories.
Scientific Facts and Manufacturer Knowledge
A substantial volume of research now supports the association between paraquat exposure and Parkinson’s disease. Major studies include findings from:
- American Journal of Epidemiology (2009): 2.5x increased Parkinson’s risk
- Environmental Health Perspectives (2011): Combined exposures increase risk x6
- JAMA Neurology (2025): Residential proximity increases risk significantly
- Multiple NIH-funded agricultural health studies also support the association
This growing scientific consensus is one of the strongest drivers of ongoing litigation.
Recent News and Notable Developments
The paraquat litigation has moved rapidly through both federal and state systems, with several major updates in 2025.
Federal MDL 3004 – Illinois
- October 2025: The judge overseeing federal paraquat lawsuits extended the stay on all deadlines until January 2026 to allow additional time for potential global settlement negotiations .
Media Spotlight
- September 2025: The New York Times published “The Clue to Unlocking Parkinson’s May Be All Around Us,” highlighting growing national attention to paraquat exposure and environmental toxin risks .
Key State Court Ruling – Pennsylvania
- July 18, 2025: A Pennsylvania judge denied Chevron and Syngenta’s attempts to remove paraquat lawsuits from Philadelphia’s mass tort court, calling the request “daft.” The defendants sought to dismiss 938 out-of-state plaintiffs, but the court held that Philadelphia’s complex litigation system is well-equipped to manage mass torts and that the defendants failed to show access to proof would be impaired. The judge also emphasized Pennsylvania’s strong interest in the case based on Chevron’s incorporation in the state.
Settlements and Upcoming Trials
Philadelphia’s first paraquat trial, initially scheduled for August 2025, settled before trial. A second trial set for October 2025 has also settled. These early case resolutions indicate defendants may prefer settlement to jury verdicts.
Following these settlements, the litigation now centers around two major 2026 bellwether trial dates that could establish case values and potentially drive global settlement discussions: January and April of 2026.
Additional filings exist in Delaware, though no trial dates have been set.
Frequently Asked Questions
Who may be eligible for a paraquat claim?
Eligibility for a paraquat claim typically includes the following criteria:
- Used, mixed, or applied herbicides containing paraquat after 1964
- At least 8 days of lifetime use and/or exposure
- Diagnosed with Parkinson’s after paraquat exposure
- Minimum 7 years between first exposure and diagnosis
- Age 41 or older at intake
- Not currently represented by an attorney
- SOL limitations apply in Alabama, Idaho, Maine, Michigan, New York, and Virginia
- Must confirm a valid U.S. SSN
Which products contain paraquat?
Paraquat appears in Gramoxone, Blanco, Devour, Firestorm, Helmquat, Para-Shot 30, Parazone, and Tota-col.
Where is paraquat used?
Primarily on farms, across industrial agriculture, orchards, cotton fields, and other high-acreage operations.
How does exposure occur?
Through mixing, loading, application, inhalation, skin contact, and environmental drift, especially for those living near treated fields.
Explore Mass Tort Co-Counsel Opportunities
The paraquat litigation is supported by extensive scientific research, a large exposed population, and defendants with substantial resources and documented awareness of potential risks. With major settlements already occurring and pivotal trials on the horizon in January and April 2026, this tort continues to represent a significant opportunity for firms seeking to help affected individuals secure accountability and compensation.
If your firm is evaluating paraquat cases, now is the time to understand the scientific foundation, legal landscape, and upcoming milestones that may shape settlement values nationwide. Contact us today to learn more.
